Recent

% | $
Quotes you view appear here for quick access.

Affymax, Inc. Message Board

  • thegreycorner thegreycorner Mar 9, 2013 12:17 AM Flag

    March 14th Conference Call: Trying to Justify Selling DEATH DRUG to Unsuspecting Patients

    I want to hear what $1 million salaries buy. I want to hear what sort of people you can buy for CEO, CMO, CCO positions. What type of people will try to justify selling the DEATH DRUG.

    If they do not apologize and advocate shutting down AFFY immediately, there should be some sort of investigation.

    These people try to gladly take credit for any successes. Now they must step up and take RESPONSIBILITY FOR SELLLING DEATH DRUG TO POOR UNSUSPECTING PATIENTS. Thank you.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • You still have not covered yet?

    • Actually there were very strong warnings on the label. I will post the warning. Also 25,000 people in Phase 3 and no reaction like this. The product is OK, it was production or something else. We will know soon,this is label warning from FDA:

      Also there were changes to label in December 2012. I copied from fda.gov:
      Omontys (Peginesatide) Injection
      Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – December 2012

      Summary View

      CONTRAINDICATIONS
      Serious allergic reactions to OMONTYS which may include anaphylaxis

      WARNINGS AND PRECAUTIONS
      Serious Allergic Reactions
      Serious allergic reactions, including anaphylactic reactions, hypotension, bronchospasm, angioedema and generalized pruritus, may occur in patients treated with Omontys. Immediately and permanently discontinue Omontys and administer appropriate therapy if a serious allergic reaction occurs

 
AFFY
0.067-0.0010(-1.47%)Jul 25 3:25 PMEDT